Bayer’s Aspirin/Phytosterols Combination May Draw FDA Warning
This article was originally published in The Pink Sheet Daily
Executive Summary
Bayer’s combination of aspirin and cholesterol-lowering supplement has industry stakeholders asking how FDA can avoid issuing a warning.
You may also be interested in...
Bayer Warning Letters Reinforce FDA Ban On Supplement/Drug Combinations
FDA could seize combo products and request an injunction against distribution and sales if Bayer fails to satisfy agency questions.
Bayer Warning Letters Reinforce FDA Ban On Supplement/Drug Combinations
FDA could seize combo products and request an injunction against distribution and sales if Bayer fails to satisfy agency questions.
Will Bayer Supplement-Drug Combo Draw Other Firms Into New Market?
New “integrated medicine” category begs FDA reg clarification.